Sean Lavin
Stock Analyst at BTIG
(3.09)
# 1,283
Out of 5,012 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $14.87 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $67.73 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $313.45 | +2.09% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $98.33 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $34.13 | +40.64% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $150.25 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $18.16 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $177.62 | -54.96% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $9.03 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $57.75 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $133.02 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $95.90 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $66.03 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $76.72 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.87
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $67.73
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $313.45
Upside: +2.09%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $98.33
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $34.13
Upside: +40.64%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $150.25
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $18.16
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $177.62
Upside: -54.96%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $9.03
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $57.75
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $133.02
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $95.90
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $66.03
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $76.72
Upside: -